卡培他滨所致手足综合征 - Suppr

Suppr

超能文献

Hand-foot syndrome due to capecitabine.

作者信息

Surjushe Amar, Vasani Resham, Medhekar Sudhir, Thakre Minal, Saple D G

出版信息

Indian J Dermatol. 2008 Jan;53(1):43-4. doi: 10.4103/0019-5154.39747.

DOI:10.4103/0019-5154.39747

PMID:19967024

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2784591/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1afa/2784591/71f4efeb89c2/IJD-53-43-g001.jpg

相似文献

Hand-foot syndrome due to capecitabine.

Indian J Dermatol. 2008 Jan;53(1):43-4. doi: 10.4103/0019-5154.39747.

Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine.

Oncology (Williston Park). 2004 Aug;18(9):1161-8, 1173; discussion 1173-6, 1181-4.

Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy.

J Clin Pharmacol. 2004 Oct;44(10):1166-72. doi: 10.1177/0091270004268321.

The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.

Australas J Dermatol. 2016 Feb;57(1):e14-6. doi: 10.1111/ajd.12224. Epub 2014 Dec 13.

Small-Fiber Neuropathy Associated with Capecitabine (Xeloda)-induced Hand-foot Syndrome: A Case Report.

J Clin Neuromuscul Dis. 2006 Mar;7(3):128-32. doi: 10.1097/01.cnd.0000211401.19995.a2.

SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome.

Cancer Chemother Pharmacol. 2020 Apr;85(4):785-792. doi: 10.1007/s00280-020-04053-9. Epub 2020 Mar 19.

Evaluation of patient-reported severity of hand-foot syndrome under capecitabine using a Markov modeling approach.

Cancer Chemother Pharmacol. 2020 Sep;86(3):435-444. doi: 10.1007/s00280-020-04128-7. Epub 2020 Aug 27.

Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?

Cureus. 2018 Mar 30;10(3):e2397. doi: 10.7759/cureus.2397.

[Management of capecitabine-induced hand-foot syndrome by local phytotherapy].

Wien Med Wochenschr. 2007;157(13-14):337-42. doi: 10.1007/s10354-007-0435-5.

The contribution of keratinocytes in capecitabine-stimulated hand-foot-syndrome.

Environ Toxicol Pharmacol. 2017 Jan;49:81-88. doi: 10.1016/j.etap.2016.12.001. Epub 2016 Dec 5.

引用本文的文献

Unveiling the Complexities: Exploring Mechanisms of Anthracyclineinduced Cardiotoxicity.

Curr Cardiol Rev. 2025;21(2):42-77. doi: 10.2174/011573403X322928241021100631.

Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome - A literature review.

An Bras Dermatol. 2023 May-Jun;98(3):302-309. doi: 10.1016/j.abd.2022.05.004. Epub 2023 Feb 17.

Capecitabine induced Hand-Foot Syndrome: Report of two cases.

Med J Armed Forces India. 2013 Jan;69(1):65-7. doi: 10.1016/j.mjafi.2012.01.009. Epub 2012 Aug 14.

An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?

Indian J Pharmacol. 2010 Oct;42(5):326-8. doi: 10.4103/0253-7613.70401.

本文引用的文献

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

J Clin Oncol. 1999 Feb;17(2):485-93. doi: 10.1200/JCO.1999.17.2.485.

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

Ann Intern Med. 1984 Dec;101(6):798-9. doi: 10.7326/0003-4819-101-6-798.

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.

Invest New Drugs. 1990 Feb;8(1):57-63. doi: 10.1007/BF00216925.

Chemotherapy-induced acral erythema.

J Am Acad Dermatol. 1991 Mar;24(3):457-61. doi: 10.1016/0190-9622(91)70073-b.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Hand-foot syndrome due to capecitabine.

作者信息

Surjushe Amar, Vasani Resham, Medhekar Sudhir, Thakre Minal, Saple D G

出版信息

Indian J Dermatol. 2008 Jan;53(1):43-4. doi: 10.4103/0019-5154.39747.

DOI:10.4103/0019-5154.39747

PMID:19967024

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2784591/

Abstract

摘要

相似文献

Hand-foot syndrome due to capecitabine.

Indian J Dermatol. 2008 Jan;53(1):43-4. doi: 10.4103/0019-5154.39747.

Coming to grips with hand-foot syndrome. Insights from clinical trials evaluating capecitabine.

Oncology (Williston Park). 2004 Aug;18(9):1161-8, 1173; discussion 1173-6, 1181-4.

Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy.

J Clin Pharmacol. 2004 Oct;44(10):1166-72. doi: 10.1177/0091270004268321.

The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.

Australas J Dermatol. 2016 Feb;57(1):e14-6. doi: 10.1111/ajd.12224. Epub 2014 Dec 13.

Small-Fiber Neuropathy Associated with Capecitabine (Xeloda)-induced Hand-foot Syndrome: A Case Report.

J Clin Neuromuscul Dis. 2006 Mar;7(3):128-32. doi: 10.1097/01.cnd.0000211401.19995.a2.

SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome.

Cancer Chemother Pharmacol. 2020 Apr;85(4):785-792. doi: 10.1007/s00280-020-04053-9. Epub 2020 Mar 19.

Evaluation of patient-reported severity of hand-foot syndrome under capecitabine using a Markov modeling approach.

Cancer Chemother Pharmacol. 2020 Sep;86(3):435-444. doi: 10.1007/s00280-020-04128-7. Epub 2020 Aug 27.

Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?

Cureus. 2018 Mar 30;10(3):e2397. doi: 10.7759/cureus.2397.

[Management of capecitabine-induced hand-foot syndrome by local phytotherapy].

Wien Med Wochenschr. 2007;157(13-14):337-42. doi: 10.1007/s10354-007-0435-5.

The contribution of keratinocytes in capecitabine-stimulated hand-foot-syndrome.

Environ Toxicol Pharmacol. 2017 Jan;49:81-88. doi: 10.1016/j.etap.2016.12.001. Epub 2016 Dec 5.

引用本文的文献

Unveiling the Complexities: Exploring Mechanisms of Anthracyclineinduced Cardiotoxicity.

Curr Cardiol Rev. 2025;21(2):42-77. doi: 10.2174/011573403X322928241021100631.

Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome - A literature review.

An Bras Dermatol. 2023 May-Jun;98(3):302-309. doi: 10.1016/j.abd.2022.05.004. Epub 2023 Feb 17.

Capecitabine induced Hand-Foot Syndrome: Report of two cases.

Med J Armed Forces India. 2013 Jan;69(1):65-7. doi: 10.1016/j.mjafi.2012.01.009. Epub 2012 Aug 14.

An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?

Indian J Pharmacol. 2010 Oct;42(5):326-8. doi: 10.4103/0253-7613.70401.

本文引用的文献

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

J Clin Oncol. 1999 Feb;17(2):485-93. doi: 10.1200/JCO.1999.17.2.485.

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

Ann Intern Med. 1984 Dec;101(6):798-9. doi: 10.7326/0003-4819-101-6-798.

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion.

Invest New Drugs. 1990 Feb;8(1):57-63. doi: 10.1007/BF00216925.

Chemotherapy-induced acral erythema.

J Am Acad Dermatol. 1991 Mar;24(3):457-61. doi: 10.1016/0190-9622(91)70073-b.